Camp, Angelique S
University of North Carolina at Chapel Hill
3 papers on CoChat
Most cited papers
- Verified
Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
Bowles, D. E., McPhee, S. W., Li, C., Gray, S. J., Samulski, J. J., Camp, A. S., Li, J., Wang, B., Monahan, P. E., Rabinowitz, J. E., et al. (2012) · Molecular Therapy
Virus-based gene therapy researchNeurogenetic and Muscular Disorders Research
Cited by 400
- Verified
Gene Therapy of Canavan Disease: AAV-2 Vector for Neurosurgical Delivery of Aspartoacylase Gene ( ASPA ) to the Human Brain
Janson, C., McPhee, S., Bilaniuk, L., Haselgrove, J., Testaiuti, M., Freese, A., Wang, D.-J., Shera, D., Hurh, P., Rupin, J., et al. (2002) · Human Gene Therapy
Virus-based gene therapy researchLysosomal Storage Disorders Research
Cited by 255
- Verified
Immune responses to AAV in a phase I study for Canavan disease
McPhee, S. W. J., Janson, C. G., Li, C., Samulski, R. J., Camp, A. S., Francis, J., Shera, D., Lioutermann, L., Feely, M., Freese, A., et al. (2006) · The Journal of Gene Medicine
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 241
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free